Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03666247 · ClinicalTrials.gov registry record · NA
Mobile Messaging Intervention to Present New HIV Prevention Options for Men Who Have Sex With Men (MSM)
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 1,229
- Enrollment target
NCT03666247 is a NA study that has completed, run by Emory University. The registered enrollment target is 1,229 participants.
The verdict
NCT03666247, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,229 participants
- Enrollment target
Study Summary
The study will evaluate the use and effectiveness of mobile-messaging platforms as a public health strategy for improving sexual health outcome measures among men who have sex with men (MSM) by determining whether exposure to the message-delivery platform results in improvements in participants' self-reported sexual health and prevention behaviors, beliefs and attitudes. The study will enroll men into a randomized controlled trial. Participants randomized to the messaging intervention will have access to a smartphone-based messaging platform for three months while those assigned to the waitlist group will be offered access to the messaging platform after all follow up is complete. Participants will complete surveys at baseline, after the end of the 3 month intervention, and follow up surveys 6 and 9 months after the baseline survey.
Interventions
- BEHAVIORAL Waitlist
- BEHAVIORAL HealthMindr Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,229 participants |
| Start Date | 2018-01-24 |
| Est. Completion | 2019-12-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03666247
The ClinicalTrials.gov registry entry for NCT03666247 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,229 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Waitlist is the first listed.
NCT03666247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03666247 about?
NCT03666247 is a clinical study titled "Mobile Messaging Intervention to Present New HIV Prevention Options for Men Who Have Sex With Men (MSM)". The study will evaluate the use and effectiveness of mobile-messaging platforms as a public health strategy for improving sexual health outcome measures among men who have sex with men (MSM) by determining whether exposure to the message-delivery platform results in improvements in participants' sel...
What is the current status of trial NCT03666247?
This trial is currently completed. It is a NA study. The enrollment target is 1,229 participants. The study started on 2018-01-24. Estimated completion is 2019-12-18.
What interventions are being tested in trial NCT03666247?
The interventions under investigation include: Waitlist (BEHAVIORAL), HealthMindr Application (BEHAVIORAL).
Who is sponsoring clinical trial NCT03666247?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.